Our Managing Directors have over 70 years of combined healthcare industry and investment expertise. We are deeply passionate about finding and building great healthcare companies.
Our investment team is supplemented by a team of Special Investment Partners who have decades of experience building industry-leading companies. We tap this powerful resource to help our portfolio companies achieve their maximum potential.
Mr. Shroff is a Managing Partner of Galen Partners. With over twenty years of experience in building healthcare companies, Mr. Shroff has acquired deep expertise, and demonstrated strong leadership in working with entrepreneurs to maximize shareholder value in the areas of therapeutic devices, diagnostics, capital equipment, specialty supplies distribution, consumer driven healthcare, homecare based solutions and technology enabled services. Successful Galen portfolio companies in which Mr. Shroff played a key leadership role include: Acura Pharmaceuticals, Aperio, Cambrooke Medical Foods, Dow Pharmaceutical Sciences, Encore Medical, JDS Pharmaceuticals, Lumenos, MiniMed, National Rehab Equipment, Nautilus Neurosciences, and Tactile Systems.
Prior to joining Galen in 1997, Mr. Shroff was a Principal at The Wilkerson Group, a leading medical products management consulting firm, with a client base including pharmaceutical, diagnostic, device and biotech companies, as well as a few select venture capital firms. Mr. Shroff started his career at Schering-Plough Pharmaceuticals where he directed marketing, sales, and Phase IV clinical development for the company’s high growth biotech business in France and was responsible for the launch of alpha-Interferon in several new indications.
Mr. Shroff is Vice-Chairman for $800 million Westchester Medical Center Public Benefit Corporation, as well as Chairman of its Foundation. Since 2004, he has served on Advisory Committees to Boston University Medical School and The Center for Global Health and Development. Mr. Shroff is on the advisory board of the Joslin Diabetes Center. He is a frequent speaker on healthcare market trends, winning medical product and service business models, and the private equity investment climate.
Mr. Shroff earned an M.B.A. from the Wharton School and a B.A. in biological science from Boston University.
Mr. Shapiro was a Managing Director of The Wilkerson Group, where he led the medical devices practice. Prior to joining The Wilkerson Group, he was Director of Advanced Ramp;D and New Business Development for Becton, Dickinson and Company, and spent eight years at Union Carbide Clinical Diagnostics, becoming engineering group leader.
Mr. Shapiro currently serves on the Board of Directors of Tactile Systems Technology, Inc.
He earned a B.S. from the Massachusetts Institute of Technology and a M.S. from the University of California at Berkeley.
Mr. Williams served as President of Pyxis Corporation, a portfolio company of Galen I. Pyxis was one of the nation’s most successful public offerings in 1992 and led to a billion-dollar merger with Cardinal Health, Inc.
Previously, Mr. Williams spent 20 years with Johnson amp; Johnson, Howmedica and DePuy, closely involved with the development and marketing of numerous medical devices, capital goods and services, and software applications for the healthcare marketplace.
Mr. Williams is the Founder and President of Faranhyll Foundation, Inc., whose charter is to foster value-based leadership in corporate life and is the author of Wrestling with Destiny. He serves on the Board of Directors of several of Galen’s privately held portfolio companies.
For the last twenty-two years, Ms. Starkey has served as Founder, Chairman, and CEO of Chamberlin Edmonds amp; Associates, Inc., a former Galen Partners Company. Chamberlin Edmonds is a financial services firm designed to locate government reimbursement for previously uninsured, medically indigent patients. The Company completed its successful sale in May of 2008.
Ms. Starkey is a graduate of Springhill College with a Masters Degree from Georgia State University. She currently serves on several private company boards and is on the Executive Committee for Baddour Memorial Center, a privately run residential center for challenged adults.
Mr. Wesson joined Galen in 1991 after serving as a Senior Vice President and Managing Director in the Corporate Finance Division at Smith Barney, where he worked for over 23 years.
During his tenure at Smith Barney, Mr. Wesson directed the Major Account Group and was Senior Managing Director in charge of the East Coast region. Mr. Wesson was also Chairman of the Valuation and Opinion Committee for Corporate Finance. In this capacity, he was ultimately responsible for all of the valuation and opinions given by Smith Barney.
Mr. Wesson currently serves on the Board of Directors of MedAssets (Vice Chairman), Derma Sciences, Acura Pharmaceuticals, and TPS. Mr. Wesson is a past trustee of Colgate University for nine years and had served as President of Colgate’s Alumni Corporation Board of Directors. He also serves as Chairman of the Board of the Overlook Hospital Foundation.
He earned a B.A. from Colgate University and a M.B.A. from Columbia University’s Graduate School of Business.
Ms. Bauer joined Galen in 2007. Prior to joining the firm, Ms. Bauer was the Controller/ Chief Financial Officer for Bedrock Capital Partners, a cross-over fund, focused on early stage information technology and healthcare companies. Prior to Bedrock, Ms. Bauer was a Tax Manager in the Financial Services Practice of PriceWaterhouseCoopers’ Boston office, where she was responsible for the tax consulting and compliance for several private equity clients and high net worth individuals.
Ms. Bauer graduated Summa Cum Laude from University of Massachusetts at Amherst with a BA in Business Administration with a concentration in Accounting.
Mr. Wesson joined Galen in 1991 after serving as a Senior Vice President and Managing Director in the Corporate Finance Division at Smith Barney, where he worked for over 23 years.
During his tenure at Smith Barney, Mr. Wesson directed the Major Account Group and was Senior Managing Director in charge of the East Coast region. Mr. Wesson was also Chairman of the Valuation and Opinion Committee for Corporate Finance. In this capacity, he was ultimately responsible for all of the valuation and opinions given by Smith Barney.
Mr. Wesson currently serves on the Board of Directors of MedAssets (Vice Chairman), Derma Sciences, Acura Pharmaceuticals, and TPS. Mr. Wesson is a past trustee of Colgate University for nine years and had served as President of Colgate’s Alumni Corporation Board of Directors. He also serves as Chairman of the Board of the Overlook Hospital Foundation.
He earned a B.A. from Colgate University and a M.B.A. from Columbia University’s Graduate School of Business.
Dr. Wilkerson co-founded Galen in 1990. Dr. Wilkerson has focused on healthcare throughout his career, beginning as a Group Product Director for Ortho Diagnostics Inc., a Johnson & Johnson company. He was with Smith Barney as a Vice President specializing in medical analysis and research before moving to Channing, Weinberg & Co., Inc. in 1980 – the firm he purchased and turned into The Wilkerson Group, a leading healthcare consultancy sold to IBM.
Dr. Wilkerson currently serves on the Board of Directors of several of Galen’s privately held portfolio companies including Cardiva, Quotient BioDiagnostics Holdings, and TPS. Dr. Wilkerson is the immediate past Chairman of Atlantic Health Systems, a New Jersey hospital system, is a trustee and former President of the Museum of American Folk Art and founder of the E. L. Rose Conservancy. He earned a Ph.D. from Cornell University and is a member of the Cornell University Council and immediate past Chairman of the College of Agricultural and Life Sciences advisory board.
William R. Grant, co-founder and former Chairman of Galen died April 15 at home in Manhattan after a year’s illness from metastatic melanoma. He was 82.
He was a former President and Vice Chairman of Smith Barney, Harris Upham & Co., Inc. and retired from Galen at the end of 2006. Mr. Grant served as an active director of several public companies until his illness.
Born in Brooklyn in 1925, he was the only child of William Vincent Grant and Adelaide Marshall Grant. He graduated from Chaminade High School in 1942 and in 1994 was inducted into the Chaminade High School Alumni Hall of Fame. He interrupted his education in 1943 to enlist in the U.S. Navy and served as an officer on a destroyer in the Pacific. In 1946, he enrolled in Union College and graduated in 1949 with a degree in chemical engineering. A devoted supporter of his alma mater, he served on the Board of Trustees for 20 years and was named Trustee Emeritus in 1992.
In 1952, Mr. Grant joined Smith Barney where he rose from drug and chemical analyst to Head of Research by his early thirties and became President of Smith Barney amp; Co. in 1971. Mr. Grant became Vice Chairman of Smith Barney, Harris Upham amp; Co. and was a frequent guest on “Wall Street Week.”
He is widely recognized as a leader in the development of professional institutional research. He participated in the financing of many healthcare companies, including G.D. Searle (Monsanto), A.H. Robins (American Home Products), Marion Laboratories (Aventis) and SmithKline Beecham (GlaxoSmithKline) serving as a Director of the company for twenty-four years.
Mr. Grant left Smith Barney in 1978 and spent a short time in Boston as Vice Chairman of Endowment Management and Research Company. In 1979, he returned to New York City to become President and eventually the Chairman of the Board of MacKay-Shields Financial Corporation, which grew to a $3 billion money management firm. In 1984, MacKay-Shields was acquired by New York Life Insurance Company, and Mr. Grant became Chairman of New York Life International Investments and a member of the Board of Directors of New York Life.
In 1990, Mr. Grant returned “to my first business love, financing small healthcare companies". With John Wilkerson and Bruce Wesson, former colleagues from Smith Barney, Mr. Grant co-founded Galen Associates. Among Galen’s successful investments have been MiniMed, Inc. and Ocular Sciences, Inc. Dr. Wilkerson stated that “Bill Grant was the consummate Partner. He set Galen’s culture and early direction. In 1990, he single-handedly convinced investors to place their funds and faith in our start-up operation. As we became successful, Bill made sure we stayed true to our founding principles: passion for the healthcare industry, responsibility to our investors and compassion for all those we touched”.
Mr. Grant has been a director of a dozen public companies including Allergan, Fluor Corporation, MiniMed, Inc., New York Life Insurance Company, Seagull Energy Corporation, SmithKline Beecham and Witco Corporation. Active directorships at the onset of his illness were Massey Energy, Advanced Medical Optics, Quest Diagnostics, Vasogen and Interaudi Bank, where he was Vice Chairman. He was also a long-time advisor to the GE Investment Corporation and the Securities and Exchange Commission. He was a former Trustee of the Mary Flagler Cary Charitable Trust, Union College, Cold Spring Harbor Research Labs and The New York Botanical Garden.
Mr. Grant believed that financial assistance should be combined with corporal works of charity. For many years, he volunteered in a soup kitchen on Saturday mornings from which he derived great satisfaction. Mr. Grant was a member of the Order of Malta and a Trustee and former Vice Chairman of the Gregorian University Foundation.
He is survived by his wife, Adele Grant, his daughters, Debbie Grant and Elise Lauinger, his son, Byron, and two grandchildren, Jeremy and Molly Hall Seeley.